Molecular components of striatal plasticity: The various routes of cyclic AMP pathways

Developmental Neuroscience

Volumn 20, Issue 2-3, 1998, Pages 204-215

  Rajadhyaksha, Anjali ^a   Leveque, Jean Christophe ^a   Macías, Wendy ^a   Barczak, Amy ^a   Konradi, Christine ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Ca2+ calmodulin kinase; Calcineurin; Cyclic AMP; Cyclic AMP response element binding protein; DARPP 32; Dopamine; N methyl D aspartate; Protein kinase A; Protein phosphatase 1; Striatum

Indexed keywords

CALCINEURIN; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHOPROTEIN DARPP 32; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN KINASE (CALCIUM,CALMODULIN); TRANSCRIPTION FACTOR;

ARTICLE; CORPUS STRIATUM; GENE EXPRESSION REGULATION; NERVE CELL CULTURE; NERVE CELL PLASTICITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0031873794     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017314     Document Type: Article

References (114)

1. Matthies H: In search of cellular mechanisms of memory. Prog Neurobiol 1989;32:277-349.
2. Stanton PK, Sarvey JM: Blockade of long-term potentiation in rat hippocampal CA1 region by inhibitors of protein synthesis. J Neurosci 1984;4:3080-3088.
3. Deadwyler SA, Dunwiddie T, Lynch G: A critical level of protein synthesis is required for long-term potentiation. Synapse 1987;1:90-95.
4. Bailey CH, Bartsch D, Kandel ER: Toward a molecular definition of long-term memory storage. Proc Natl Acad Sci USA 1996;93: 13445-13452.
5. Schulman H: Protein phosphorylation in neuronal plasticity and gene expression. Curr Opin Neurobiol 1995;5:375-381.
6. Roche KW, Tingley WG, Huganir RL: Glutamate receptor phosphorylation and synaptic plasticity. Curr Opin Neurobiol 1994;4:383-388.
7. Nairn AC, Shenolikar S: The role of protein phosphatases in synaptic transmission, plasticity and neuronal development. Curr Opin Neurobiol 1992;2:296-301.
8. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr: Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44:559-577.
9. Langston JW: The etiology of Parkinson's disease with emphasis on the MPTP story. Neurology 1996;47:S153-160.
10. DiFiglia M: Excitotoxic injury of the neostriatum: A model for Huntington's disease. Trends Neurosci 1990;13:286-289.
11. Bernheimer H, Birkmayer W, Homykiewicz O, Jellinger K, Seitelberger F: Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973;20:415-455.
12. Hornykiewicz O: Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: Possible neurochemical mechanisms. Adv Neurol 1993;60:140-147.
13. Burns RS: Subclinical damage to the nigrostriatal dopamine system by MPTP as a model of preclinical Parkinson's disease: A review. Acta Neurol Scand Suppl 1991;136:29-36.
14. Calne DB, Langston JW, Martin WR, Stoessl AJ, Ruth TJ, Adam MJ, Pate BD, Schulzer M: Positron emission tomography after MPTP: Observations relating to the cause of Parkinson's disease. Nature 1985;317:246-248.
15. Self DW, Nestler EJ: Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci 1995;18:463-495.
16. Hyman SE: Addiction to cocaine and amphetamine. Neuron 1996;16:901-904.
17. Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA: Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psyhiatry 1992;49: 935-942.
18. Siegel BV Jr, Buchsbaum MS, Bunney WE Jr, Gottschalk LA, Haier RJ, Lohr JB, Lottenberg S, Najafi A, Nuechterlein KH, Potkin SG, et al: Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry 1993;150:1325-1336.
19. Heckers S: Neuropathology of schizophrenia: Cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems. Schizophr Bull 1997;23:403-421.
20. Busatto GF, Kerwin RW: Schizophrenia, psychosis, and the basal ganglia. Psychiatr Clin North Am 1997;20:897-910.
21. Knowlton BJ, Mangels JA, Squire LR: A neostriatal habit learning system in humans. Science 1996;273:1399-1402.
22. Hyman SE, Nestler EJ: Initiation and adaptation: A paradigm for understanding psychotropic drug action. Am J Psychiatry 1996;153: 151-162.
23. Kane JM: Tardive dyskinesia: Epidemiological and clinical presentation; in Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, 1995, pp 1485-1495.
24. Nestler EJ, Hope BT, Widnell KL: Drug addiction: A model for the molecular basis of neural plasticity. Neuron 1993;11:995-1006.
25. Smith AD, Bolam JP: The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci 1990;13:259-265.
26. Somogyi P, Hodgson AJ, Smith AD: An approach to tracing neuron networks in the cerebral cortex and basal ganglia. Combination of Golgi staining, retrograde transport of horse-radish peroxidase and anterograde degeneration of synaptic boutons in the same material. Neuroscience 1979;4:1805-1852.
27. Kemp JM, Powell TP: The structure of the caudate nucleus of the cat: Light and electron microscopy. Philos Trans R Soc Lond B Biol Sci 1971;262:383-401.
28. Graybiel AM: Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 1990;13:244-254.
29. Sibley DR, Monsma FJ Jr, McVittie LD, Gerfen CR, Burch RM, Mahan LC: Molecular neurobiology of dopamine receptor subtypes. Neurochem Int 1992;20:17S-22S.
30. Seeman P, Van Tol HHM: Dopamine receptor pharmacology. Curr Opin Neurol Neurosurg 1993;6:602-608.
31. Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR, Ciliax BJ, et al: Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 1993;90:8861-8865.
32. Albin RL, Young AB, Penney JB: The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375.
33. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, Sibley DR: D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990;250:1429-1432.
34. LeMoine C, Normand E, Guitteny AF, Fouque B, Teoule R, Bloch B: Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc Natl Acad Sci USA 1990;87:230-234.
35. 1 dopamine receptor gene. Proc Natl Acad Sci USA 1991;88:4205-4209.
36. Monsma FJ Jr, Mahan LC, McVittie LD, Gerfen CR, Sibley DR: Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci USA 1990;87:6723-6727.
37. Walaas SI, Greengard P: DARPP-32, a dopamine-and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain. J Neurosci 1984;4:84-98.
38. Ouimet CC, Miller PE, Hemmings HCJ, Walaas SI, Greengard P: DARPP-32, a dopamine-and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J Neurosci 1984;4:111-124.
39. Bischoff S, Barhanin J, Bettler B, Mulle C, Heinemann S: Spatial distributions of kainate receptor subunit mRNA in the mouse basal ganglia and ventral mesencephalon. J Comp Neurol 1997;379:541-562.
40. Chen Q, Veenman CL, Reiner A: Cellular expression of ionotropic glutamate receptor sub-units on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity. Neuroscience 1996;73:715-731.
41. Bernard V, Gardiol A, Faucheux B, Bloch B, Agid Y, Hirsch EC: Expression of glutamate receptors in the human and rat basal ganglia: Effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion. J Comp Neurol 1996; 368:553-568.
42. Chen Q, Reiner A: Cellular distribution of the NMDA receptor NR2A/2B subunits in the rat striatum. Brain Res 1996;743:346-352.
43. MacDermott AB, Mayer ML, Westbrook GL, Smith SJ, Barker JL: NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature 1986;321:519-522.
44. Hollmann M, Heinemann S: Cloned glutamate receptors. Annu Rev Neurosci 1994;17:31-108.
45. Eccles JC: Calcium in long-term potentiation as a model for memory. Neuroscience 1983;10: 1071-1081.
46. Lynch G, Larson J, Kelso S, Barrionuevo G, Schottler F: Intracellular injections of EGTA block induction of hippocampal long-term potentiation. Nature 1983;305:719-721.
47. Silva AJ, Stevens CF, Tonegawa S, Wang Y: Deficient hippocampal long-term potentiation in α-calcium-calmodulin kinase II mutant mice. Science 1992;257:201-206.
48. 2+/calmodulin-dependent protein kinase II. J Biol Chem 1993; 268:7863-7867.
49. Stevens CF, Tonegawa S, Wang Y: The role of calcium-calmodulin kinase II in three forms of synaptic plasticity. Curr Biol 1994;4:687-693.
50. Abeliovich A, Chen C, Goda Y, Silva AJ, Stevens CF, Tonegawa S: Modified hippocampal long-term potentiation in PKC gamma-mutant mice. Cell 1993;75:1253-1262.
51. Muller D, Buchs PA, Stoppini L, Boddeke H: Long-term potentiation, protein kinase C, and glutamate receptors. Mol Neurobiol 1991;5: 277-288.
52. King MM, Huang CY, Chock PB, Nairn AC, Hemmings HCJ, Chan KF, Greengard P: Mammalian brain phosphoproteins as substrates for calcineurin. J Biol Chem 1984;259: 8080-8083.
53. Tong G, Shepherd D, Jahr CE: Synaptic desensitization of NMDA receptors by calcineurin. Science 1995;267:1510-1512.
54. Hemmings HCJ, Williams KR, Konigsberg WH, Greengard P: DARPP-32, a dopamine-and adenosine 3′:5′-monophosphate-regulated neuronal phosphoprotein. I. Amino acid sequence around the phosphorylated threonine. J Biol Chem 1984;259:14486-14490.
55. Hemmings HCJ, Greengard P, Tung HY, Cohen P: DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 1984;310:503-505.
56. Halpain S, Girault JA, Greengard P: Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature 1990;343:369-372.
57. Gonzalez GA, Montminy MR: Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 1989;59:675-680.
58. Montminy MR, Bilezikjian LM: Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 1987; 328:175-178.
59. Sheng M, Thompson MA, Greenberg ME: CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 1991;252:1427-1430.
60. 2+/calmodulin-as well as cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1991;88:5061-5065.
61. Arias S, Alberts AS, Brindle P, Claret FX, Smeal T, Karin M, Feramisco J, Montminy M: Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 1994;370:226-229.
62. Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, Goodman RH: Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993;365:855-859.
63. Kwok RP, Lundblad JR, Chrivia JC, Richards JP, Bachinger HP, Brennan RG, Roberts SG, Green MR, Goodman RH: Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994;370:223-226.
64. Kee BL, Arias J, Montminy MR, Kee BI: Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator. J Biol Chem 1996;271:2373-2375.
65. Hagiwara M, Alberts A, Brindle P, Meinkoth J, Feramisco J, Deng T, Karin M, Shenolikar S, Montminy M: Transcriptional attenuation following cAMP induction requires PP-1 mediated dephosphorylation of CREB. Cell 1992; 70:105-113.
66. Alberts AS, Montminy M, Shenolikar S, Feramisco JR: Expression of a peptide inhibitor of protein phosphatase 1 increases phosphorylation and activity of CREB in NIH 3T3 fibroblasts. Mol Cell Biol 1994;14:4398-4407.
67. Wadzinski BE, Wheat WH, Jaspers S, Peruski LFJ, Lickteig RL, Johnson GL, Klemm DJ: Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol Cell Biol 1993;13:2822-2834.
68. Sheng M, McFadden G, Greenberg ME: Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron 1990;4:571-582.
69. Cole RL, Konradi C, Douglass J, Hyman SE: Neuronal adaptation to amphetamine and dopamine: Molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 1995;14:813-823.
70. Konradi C, Kobierski LA, Nguyen TV, Heckers S, Hyman SE: The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum. Proc Natl Acad Sci USA 1993;90:7005-7009.
71. Konradi C, Cole RL, Heckers S, Hyman SE: Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J Neurosci 1994;14:5623-5634.
72. Konradi C, Cole RL, Green D, Senatus P, Leveque JC, Pollack A, Grossbard SJ, Hyman SE: Analysis of the proenkephalin second messenger-inducible enhancer in rat striatal cultures. J Neurochem 1995;65:1007-1015.
73. Konradi C, Leveque JC, Hyman SE: Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends upon postsynaptic NMDA receptors and calcium. J Neurosci 1996;16:4231-4239.
74. Douglass J, McKinzie AA, Pollock KM: Identification of multiple DNA elements regulating basal and protein kinase A-induced transcriptional expression of the rat prodynorphin gene. Mol Endocrinol 1994;8:333-344.
75. 2+-and stimulus duration-dependent switch for hippocampal gene expression. Cell 1996;87: 1203-1214.
76. 2+ dependent regulation in neuronal gene expression. Curr Opin Neurobiol 1997;7:419-429.
77. Deisseroth K, Bito H, Tsien RW: Signalling from synapse to nucleus: Postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity. Neuron 1996;16: 89-101.
78. Bourtchuladze R, Frenguelli B, Blendie J, Cioffi D, Schütz G, Silva AJ: Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 1994;79:59-68.
79. Yin JCP, Wallach JS, Del Vecchio M, Wilder EL, Zhou H, Quinn WG, Tully T: Induction of a dominant negative CREB transgene specifically blocks long-term memory in drosophila. Cell 1994;79:49-58.
80. Stevens CF: CREB and memory consolidation. Neuron 1994;13:769-770.
81. Frank DA, Greenberg ME: CREB: A mediator of long-term memory from mollusks to mammals. Cell 1994;79:5-8.
82. Impey S, Villacres EC, Poser S, Chavkin C, Storm DR: Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus. Neuron 1996;16:973-982.
83. Riabowol KT, Fink S, Gilman MZ, Walsh DA, Goodman RH, Feramisco JR: The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMP-responsive enhancer elements. Nature 1988; 336:83-86.
84. Nigg EA, Hilz H, Eppenberger HM, Dutly F: Rapid and reversible translocation of the catalytic subunit of cAMP-dependent protein kinase type II from the Golgi complex to the nucleus. EMBO J 1985;4:2801-2806.
85. Ginty DD, Kornhauser JM, Thompson MA, Bading H, Mayo KE, Takahashi JS, Greenberg ME: Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and circadian clock. Science 1993;260:238-241.
86. Deisseroth K, Tsien RW: Calmodulin translocation to the nucleus mediates rapid synaptic control of CREB phosphorylation in hippocampal neurons. Soc Neurosci Abstr 1997;23: 311.
87. Liu FC, Graybiel AM: Spatiotemporal dynamics of CREB phosphorylation: Transient versus sustained phosphorylation in the developing striatum. Neuron 1996;17:1133-1144.
88. Paul ML, Graybiel AM, David JC, Robertson HA: D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J Neurosci 1992;12:3729-3742.
89. Snyder-Keller AM: Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: Importance of NMDA activation and relevance to sensitization phenomena. Exp Neurol 1991;113:155-165.
90. O'Boyle KM, Gaitanopoulos DE, Brenner M, Waddington JL: Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor. Neuropharmacology 1989;28:401-405.
91. Wong EH, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL: The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 1986;83: 7104-7108.
92. Metzger H, Lindner E: The positive inotropic-acting forskolin, a potent adenylate cyclase activator. Arzneimittelforschung 1981;31:1248-1250.
93. Tingley WG, Ehlers MD, Kameyama K, Doherty C, Ptak JB, Riley CT, Huganir RL: Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J Biol Chem 1997;272:5157-5166.
94. Tingley WG, Roche KW, Thompson AK, Huganir RL: Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain. Nature 1993;364:70-73.
95. Premkumar LS, Auerbach A: Stoichiometry of recombinant N-methyl-D-aspartate receptor channels inferred from single-channel current patterns. J Gen Physiol 1997;110:485-502.
96. Paterson JM, Smith SM, Harmar AJ, Antoni FA: Control of a novel adenylyl cyclase by calcineurin. Biochem Biophys Res Commun 1995;214:1000-1008.
97. Katsushika S, Chen L, Kawabe J-I, Nilakantan R, Halnon NJ, Homcy CJ, Ishikawa Y: Cloning and characterization of a sixth adenylyl cyclase isoform: Types V and VI constitute a subgroup within the mammalian adenylyl cyclase family. Proc Natl Acad Sci USA 1992;89:8774-8778.
98. Polli JW, Kincaid RL: Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation. J Neurosci 1994;14:1251-1261.
99. Brandon EP, Idzerda RL, McKnight GS: PKA isoforms, neural pathways, and behaviour: Making the connection. Curr Opin Neurobiol 1997;7:397-403.
100. Hempel CM, Vincent P, Adams SR, Tsien RY, Selverston AI: Spatio-temporal dynamics of cyclic AMP signals in an intact neural circuit. Nature 1996;384:166-169.
101. Cepeda C, Buchwald NA, Levine MS: Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc Natl Acad Sci USA 1993;90:9576-9580.
102. 2+ block of NMDA receptor channels as a mechanism of modulation. Nature 1992;356:521-523.
103. Ben-Ari Y, Aniksztejn L, Bregestovski P: Protein kinase C modulation of NMDA currents: An important link for LTP induction. Trends Neurosci 1992;15:333-339.
104. Nishi H, Snyder GL, Greengard P: Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J Neurosci 1997;17:8147-8155.
105. Bear MF: A synaptic basis for memory storage in the cerebral cortex. Proc Natl Acad Sci USA 1996;93:13453-13459.
106. Brown TH, Chapman PF, Kairiss EW, Keenan CL: Long-term synaptic potentiation. Science 1988;242:724-728.
107. Bear MF, Malenka RC: Synaptic plasticity: LTP and LTD. Curr Opin Neurobiol 1994;4: 389-399.
108. Harada K, Nagatsugu Y, Ito H, Shingai R: Intracellular cAMP regulates the response to NMDA in hippocampal neurons. Neuroreport 1991;2:673-676.
109. Blitzer RD, Wong T, Nouranifar R, Iyengar R, Landau EM: Postsynaptic cAMP pathway gates early LTP in hippocampal CA1 region. Neuron 1995;15:1403-1414.
110. Brandon EP, Zhuo M, Huang YY, Qi M, Gerhold KA, Burton KA, Kandel ER, McKnight GS, Idzerda RL: Hippocampal long-term depression and depotentiation are defective in mice carrying a targeted disruption of the gene encoding the RI beta subunit of cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1995;92:8851-8855.
111. Desdouits F, Siciliano JC, Greengard P, Girault JA: Dopamine-and cAMP-regulated phosphoprotein DARPP-32: Phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin. Proc Natl Acad Sci USA 1995;92:2682-2685.
112. Walaas SI, Aswad DW, Greengard P: A dopamine-and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 1983;301:69-71.
113. 2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev 1994;8:2527-2539.
114. Montminy MR, Gonzalez GA, Yamamoto KK: Regulation of cAMP-inducible genes by CREB. Trends Neurosci 1990;13:184-188.